$AMRZ

Brouwer Roald purchased $70K of AMRZ

Brouwer Roald (Chief Technology Officer) purchased 1,500 shares of Amrize Ltd (AMRZ) at $46.36 on 2026-08-11.

Original reporting
SEC EDGAR · Brouwer Roald
Published Aug 13, 2026, 3:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 4:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMRZ
Neutral
low confidence
Mentioned
$AMRZ
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMRZNeutralLow
01

Why it matters

The newest disclosed fact is the CTO’s open-market purchase details (shares, price, total value, and post-transaction holdings).

02

Market read

Traders may note insider buying, but there is no accompanying fundamental catalyst in the text.

03

What to watch

No 10b5-1 plan is cited, but the filing still lacks context on motivation, timing constraints, or whether other insiders made concurrent trades.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-13, transaction dated 2026-08-11

Background

The article is an SEC Form 4 insider transaction disclosure for Amrize Ltd (AMRZ).

Company-level read

Ticker impact

$AMRZNeutralLow confidence
Context

Amrize Ltd CTO Brouwer Roald bought 1,500 shares on 2026-08-11 at $46.36, totaling $69,540, per Form 4.

Expected impact

Likely limited near-term impact; any effect is sentiment-only and typically fades unless followed by additional disclosures.

Evidence & confidence

Form 4 insider buys can signal confidence, but the filing provides no new operational or financial information and the transaction size is modest.

Market effects

No clear sector read-through from a single, modest insider purchase.

None indicated.

None indicated.

Counterpoint

The purchase may be discretionary or part of personal liquidity planning, not a forward-looking signal.

Key entities

  • Amrize Ltd

    Subject of the Form 4 insider transaction disclosure.

  • Brouwer Roald

    Chief Technology Officer who reported the open-market purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

Med

Amrize Reports Third Quarter 2026 Results

Amrize Ltd (AMRZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Amrize Reports Third Quarter 2026 Results • Revenues up 2.2% to $3,771 million • Net Income grew 3.3% to $558 million • Adjusted EBITDA increased 0.2% to $1,076 million • Margin expansion of 30 basis points in Building Materials • Completed Rapid Redi-Mix acquisition in Dallas-Fo